Abstract
IntroductionTreatment of severe chronic constipation (CC) is suboptimal. Prucalopride (PRU) is a selective high affinity 5-HT4 receptor agonist, first representative of new chemical class (dihydro-benzofurancarboxamide compounds), developed for CC treatment....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have